Gladstone Institutes Launches Capital Campaign to Accelerate a Biomedical Revolution
The $350 million Gladstone NOW campaign will raise funds to expand Gladstone's footprint, hire hundreds of additional scientists, and seize...
DNA
New England Biolabs® Announces 2024 Passion in Science Awards® Recipients
Twelve scientists to be recognized for their inspiring achievements in science mentorship, environmental stewardship, humanitarian efforts and the arts. IPSWICH,...
Ovation.io and PD Theranostics (PDTx) Complete Merger Creating a Multiomic Data Company Which Owns a Unique Population-Scale Biobank of Disease-Specific Biospecimens
Ovation owns a unique population-scale biobank of consented and linkable disease-specific biospecimens, which includes more than 1.6 million samples from...
Lucius Partners Portfolio Company, PD Theranostics, Completes its Merger with Ovation.io Creating a Multiomic Data Company Which Owns a Unique Population-Scale Biobank of Disease-Specific Biospecimens
Ovation owns a unique population-scale biobank of consented and linkable disease-specific biospecimens, which includes more than 1.6 million samples from over...
Sequentify and Dexter Collaborate to Introduce Genomic Sequencing Solutions to the Romanian Market
REHOVOT, Israel, Sept. 5, 2024 /PRNewswire/ -- Sequentify has partnered with Dexter, a Romanian distributor, to bring Sequentify's InfiniSeq™ library...
SOPHiA GENETICS Announces Validation of Novel Clinical Trial Assay Together with Precision for Medicine at World Clinical Biomarkers & CDx 2024
The companies share how their collaboration enables clinical trial enrollment for a novel cancer therapy for oncogene amplified cancers in...
Ginkgo Regains Compliance with NYSE Minimum Bid Price Requirement
BOSTON, Sept. 4, 2024 /PRNewswire/ -- Ginkgo Bioworks Holdings, Inc. (NYSE: DNA, "Ginkgo" or the "Company"), which is building the...
U.S. Physicians Overwhelmingly Support Current FDA Data Standards, Switching Studies for Interchangeable Biosimilars; Oppose Pharmacy Substitution of Non-Interchangeable Biosimilars
ARLINGTON, VA / ACCESSWIRE / September 4, 2024 / U.S. physicians overwhelmingly support maintaining the Food and Drug Administration's (FDA's)...
Telomir Pharmaceuticals Appoints Dr. Itzchak Angel, Former Head of Pharmacology at Synthelabo (Now Sanofi-Aventis), to Lead IND and INAD Applications for Human and Veterinary Indications
MIAMI, FL / ACCESSWIRE / September 4, 2024 / Telomir Pharmaceuticals, Inc. (NASDAQ:TELO) ("Telomir" or the "Company"), a pre-clinical-stage company...
InVita Healthcare Technologies Announces Successful Launch of iReferral with the University of Arkansas for Medical Sciences and the Arkansas Regional Organ Recovery Agency to Automate Organ and Tissue Donor Referrals
iReferral® streamlines the referral process by automating the identification of potential organ and tissue donors in the hospital and electronically notifying...
Femasys to Participate in Fireside Chat at the H.C. Wainwright 26th Annual Global Investment Conference
ATLANTA, Sept. 03, 2024 (GLOBE NEWSWIRE) -- Femasys, Inc., (Nasdaq: FEMY), a leading biomedical company focused on addressing significant unmet...
Rakovina Therapeutics Announces 2024 Q2 Financial Results and Provides Corporate Update
All dollar amounts reflected in Canadian dollars unless otherwise stated. VANCOUVER, British Columbia, Aug. 30, 2024 (GLOBE NEWSWIRE) -- Rakovina...
Leading Computational Scientist and Oncology Researcher Elana Fertig, PhD, Appointed New Director of Institute for Genome Sciences
Internationally-recognized for her work in developing predictive models for drug resistance in cancer treatment BALTIMORE, Aug. 30, 2024 /PRNewswire/ --...
Ginkgo Bioworks Announces Participation in the Morgan Stanley 22nd Annual Global Healthcare Conference
BOSTON, Aug. 30, 2024 /PRNewswire/ -- Ginkgo Bioworks Holdings, Inc. (NYSE: DNA), which is building the leading platform for cell...
BioCardia Announces FDA Market Clearance of Morph® DNA™ Steerable Introducer Product Family
SUNNYVALE, Calif., Aug. 29, 2024 (GLOBE NEWSWIRE) -- BioCardia, Inc. , a global leader in cellular and cell-derived therapeutics for the...
IMUNON to Host R&D Day on September 18th
R&D Discussion in New York City to Review IL-12’s Potential to Treat Ovarian Cancer Program Features Ovarian Cancer Thought Leaders,...
Tribun Health Partners With Ibex to Deliver Advanced AI Diagnostic Solutions
ARIS, FRANCE AND MONTREAL, QUEBEC / ACCESSWIRE / August 28, 2024 / Tribun Health, a leading provider of digital pathology...
West Virginia University Health System and Lifeline of Ohio Launch InVita Healthcare Technologies’ iReferral to Streamline the Organ and Tissue Donation Referral Process
MORGANTOWN, W.Va., Aug. 27, 2024 /PRNewswire/ -- The West Virginia University Health System (WVU Medicine) partnered with InVita Healthcare Technologies...
AI-based Medical Device Company Imidex and Precision Genomix Company Orbit Genomics Form Strategic Relationship to Explore the Detection of Lung Cancer in Early Stages
Computer Vision AI and Precision Genomic Collaboration Aims to Increase Early Detection Rates, Improving Survival Chances for Millions DENVER, Aug....
BioVie Announces Clinical Data Showing Epigenetic Basis for How Bezisterim May Modulate Inflammation and the Biological Aging Process at the 11th Aging Research and Drug Discovery Meeting
Bezisterim appears to possess broad homeostatic properties relevant to inflammation and human disorders related to aging Patients treated with bezisterim...